Skip to Content
Merck

Analysis of 6 cases of drug-induced pemphigus.

European journal of dermatology : EJD (2011-06-24)
Suying Feng, Wuqing Zhou, Jiechen Zhang, Peiying Jin
ABSTRACT

To study clinical and laboratory characteristics of drug-induced pemphigus. Using direct immunofluorescence (IF), indirect IF, ELISA and immunoblotting to characterize 6 patients with drug-induced pemphigus (DIP) and compared them with 20 cases of idiopathic pemphigus. All the 6 cases of DIP showed obvious itching (100%) and no damage to the oral mucosa. Five out of 6 DIP cases (83.33%) presented as pemphigus folicaeus (PF) since they contained circulating Dsg1-specific IgG, were sensitive to low doses of glucocorticoid, and had good prognosis. One case was showed as pemphigus vulgaris (PV). Dsg1-specific IgA was positive in peripheral blood of 4 cases (66.67%), and the antibody disappeared after treatment. In patients with idiopathic pemphigus, only 6 cases (30%) had mild itching, and 12 cases (60%) had oral mucosal lesions. Twelve cases (60%) were PV with anti-Dsg1 and -Dsg3 antibodies, and 8 cases (40%) were PF with anti-Dsg1 antibody only. One case (5%) had anti-Dsg1 IgA. Drug factors should be considered for pemphigus as some common antibiotics can cause pemphigus.

MATERIALS
Product Number
Brand
Product Description

USP
Cephradine, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Cephradine, ≥90.0% (Cephradine, HPLC)